The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: Epigenetics, Signalling, and Immunology, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.

We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.

 


07/10/2021

The Babraham Research Campus receives funding for barrier-busting PhD programme

Innovation and integration to develop a new generation of researchers

Studentships will foster excellent research skills and commercial know-how thanks to on-campus collaborations.


10/09/2021

Scientist Stories: Meet Tombi Makuyana

Get to know the story behind the scientist

"I really wanted to understand immunology in the hope of trying to contribute something to help my country"


06/09/2021

The Spatial Mouse Atlas: new insights into cell fate

New resource for studying development

Atlas provides insights into mouse brain and gut development


01/09/2021

Epigenetics programme welcomes Professor Kathy Niakan as honorary group leader

Professor Niakan appointed as honorary group leader

Third honorary group leader, Professor Kathy Niakan, joins the Institute.

Access our Science Facilities

Bioinformatics
Imaging
Sequencing
Biological Support Unit
Lipidomics
Biological Chemistry
Flow Cytometry
Mass Spectrometry
Gene Targeting
Imaging

The Imaging Facility provides a high quality microscopy and image analysis service for Babraham Institute scientists and the broader research community. We offer tra

Sequencing

Next Generation Sequencing technology has revolutionised post-genomics studies of gene expression, genetic regulation and nuclear dynamics. The Sequencing Facility provid

Biological Support Unit

Our state-of-the-art Biological Support Unit provides housing and care for pathogen-free rodents. It supports research across the Institute as well as providing services

Lipidomics

The Lipidomics Facility undertakes the detection and identification of lipids, with a focus on providing biological meaning to these generated lipid profiles through bios

Biological Chemistry

To provide a research interface between chemistry and biology to solve biological questions. Key services Chemical synthesis (bio-active molecules, fluorescent or i

Flow Cytometry

The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.

Mass Spectrometry

The primary role of the Facility is to apply state of the art techniques in mass spectrometry to address important biological questions, within the remit of the Institute

Gene Targeting

To deliver gene targeting capabilities including the production of transgenic mouse models. Key services Generation of mouse models; ranging from single nucleoti

 

Public Engagement intro text

Key visitor pages

Members of the public may wish to look at the following pages to find out how the Babraham Institute works with and for society:

The following pages may be of particular interest to those in the Academic community:

Members of the media and journalists may wish to visit the following sections for further details about our work:


Enhancer-associated H3K4 methylation safeguards in vitro germline competence.

Bleckwehl T, Crispatzu G, Schaaf K,

Nature communications
12 1: 01 Oct 2021

PMID: 34599190

Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases.

Arthur-Farraj P, Coleman MP,

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
1 1: 30 Sep 2021

PMID: 34595734